comparemela.com

IQVIA (NYSE:IQV – Free Report) had its price target hoisted by Citigroup from $190.00 to $225.00 in a report released on Monday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. A number of other analysts also recently issued reports on the stock. Evercore ISI cut their price target […]

Related Keywords

Constantinos Panagos ,Mutual Advisors ,Holdings Inc ,Jpmorgan Chase Co ,Laurel Wealth Advisors ,Byrne Asset Management ,Research Development Solutions ,Contract Sales Medical Solutions ,Morgan Stanley ,Company Profile ,Citigroup ,Technology Analytics Solutions ,Parkside Financial Bank ,Free Report ,Moderate Buy ,Get Free Report ,Financial Bank ,Wealth Advisors ,Asset Management ,Analytics Solutions ,Development Solutions ,Contract Sales ,Iqvia ,Nyse Iqv ,Iqv ,Medical ,Boost Price Target ,Citigroup Inc ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.